Non-alcoholic fatty liver disease fibrosis score and FIB-4 scoring system could identify patients at risk of systemic complications
Author:
Affiliation:
1. Department of Medical Health Checkup Center; Musashino Red Cross Hospital; Tokyo Japan
2. Department of Gastroenterology and Hepatology; Musashino Red Cross Hospital; Tokyo Japan
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12405/fullpdf
Reference19 articles.
1. The prevalence and etiology of elevated aminotransferase levels in the United States;Clark;Am J Gastroenterol,2003
2. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999
3. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C;Sanyal;Hepatology,2006
4. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005
5. Sampling variability of liver biopsy in nonalcoholic fatty liver disease;Ratziu;Gastroenterology,2005
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Noninvasive Liver Fibrosis Indices as Indicators of Microvascular and Macrovascular Complications in Type 2 Diabetes;Metabolic Syndrome and Related Disorders;2024-06-05
2. Performance of nonalcoholic fatty liver fibrosis score in estimating atherosclerotic cardiovascular disease risk;Nutrition, Metabolism and Cardiovascular Diseases;2023-12
3. Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver‐related events in nonalcoholic fatty liver disease;Hepatology Research;2023-07-12
4. The combination of the enhanced liver fibrosis and FIB‐4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease;Alimentary Pharmacology & Therapeutics;2023-03-26
5. Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease;World Journal of Hepatology;2022-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3